These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10081522)

  • 1. Effects of diabetes mellitus on patients with acute intermittent porphyria.
    Andersson C; Bylesjö I; Lithner F
    J Intern Med; 1999 Feb; 245(2):193-7. PubMed ID: 10081522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic metabolism protective in severe acute intermittent porphyria].
    Andersson C; Lithner F
    Lakartidningen; 2001 Dec; 98(51-52):5874-6. PubMed ID: 11806263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J; Schmauch A; Wikberg A; Dahlquist G; Andersson C
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden.
    Innala E; Andersson C
    J Intern Med; 2011 May; 269(5):538-45. PubMed ID: 21198994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria.
    Andersson C; Bjersing L; Lithner F
    J Intern Med; 1996 Oct; 240(4):195-201. PubMed ID: 8918510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
    Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E
    Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.
    Lissing M; Wester A; Vassiliou D; Floderus Y; Harper P; Sardh E; Wahlin S
    J Inherit Metab Dis; 2023 Nov; 46(6):1186-1194. PubMed ID: 37650859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden.
    Andersson C; Innala E; Bäckström T
    J Intern Med; 2003 Aug; 254(2):176-83. PubMed ID: 12859699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and financial burden of acute intermittent porphyria.
    Neeleman RA; Wagenmakers MAEM; Koole-Lesuis RH; Mijnhout GS; Wilson JHP; Friesema ECH; Langendonk JG
    J Inherit Metab Dis; 2018 Sep; 41(5):809-817. PubMed ID: 29675607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria.
    Wikberg A; Andersson C; Lithner F
    J Intern Med; 2000 Jul; 248(1):27-32. PubMed ID: 10947878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria.
    Aarsand AK; Petersen PH; Sandberg S
    Clin Chem; 2006 Apr; 52(4):650-6. PubMed ID: 16595824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
    Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria.
    Marcos J; Ibañez M; Ventura R; Segura J; To-Figueras J; Pozo OJ
    J Mass Spectrom; 2015 Jul; 50(7):929-37. PubMed ID: 26349648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study.
    Bylesjö I; Wikberg A; Andersson C
    Scand J Clin Lab Invest; 2009; 69(5):612-8. PubMed ID: 19401933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model.
    Vera-Yunca D; Serrano-Mendioroz I; Sampedro A; Jericó D; Trocóniz IF; Fontanellas A; Parra-Guillén ZP
    Mol Genet Metab; 2019 Nov; 128(3):367-375. PubMed ID: 30639045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute intermittent porphyria: Long-term follow up of 35 patients].
    Herrero C; Badenas C; Aguilera P; To-Figueras J
    Med Clin (Barc); 2015 Oct; 145(8):332-7. PubMed ID: 25194977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.